HUM — Humana Inc.

Humana Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Humana reported a solid start to 2026, with membership growth trajectory on track.
• The company expects to double individual Medicare Advantage (MA) margins in 2026, adjusted for Star ratings.
• Medical cost trends continue to outpace program funding, necessitating adjustments to benefits.
• The Medical Loss Ratio (MLR) for Q2 is expected to be slightly above 91%, reflecting a deceleration compared to Q1.

2. Strategic Updates and Business Highlights

• Humana is focusing on returning to a sustainable margin of at least 3% by 2028, with necessary progress anticipated in 2027.
• The company has made operational improvements, including centralizing teams, expanding outsourcing, and increasing automation.
• The acquisition of Max Health, a primary care organization, is expected to enhance CenterWell's market reach.
• Medicaid membership grew by approximately 50,000 lives due to new programs in Michigan, Illinois, and South Carolina.

3. Forward Guidance and Outlook

• Humana remains committed to its 2028 margin goals and is actively managing bids for the 2027 plan year.
• The company anticipates that the improved rate notice from CMS will provide more stability in the industry.
• Humana is confident in its trajectory towards top quartile Star ratings by 2028, with early engagement efforts showing positive results.

4. Challenges and Points of Concern

• Medical cost trends are a significant concern, as they continue to exceed funding levels, prompting potential benefit adjustments.
• The company acknowledged that the gap between funding and medical cost trends is larger than in previous years, which could impact future margins.
• There is uncertainty regarding the full cost profile of new members, which complicates bid strategies for 2027.
• The elevated Incurred But Not Reported (IBNR) reserves, which grew 35% sequentially against a 22% membership growth, indicate a conservative approach to claims reserves.

5. Notable Q&A Insights

• Management emphasized the need for careful monitoring of claims trends, particularly in the second quarter, to identify potential issues early.
• The transformation office established to oversee key initiatives is functioning effectively, providing resources and support to various business units.
• There is a focus on retaining members while managing benefits to protect margins, with retention being a priority in the bid strategy.
• The company is taking a disciplined approach to pricing and benefit adjustments, aiming to minimize churn and maintain member satisfaction.

Overall, Humana's Q1 2026 results reflect a commitment to strategic growth and operational efficiency, while navigating challenges related to medical cost trends and funding environments.